1887

Abstract

Insertion of the gene into a I restriction enzyme site of a 5∙7 kb dIII fragment of the fowlpox virus (FPV) genome resulted in the generation of stable recombinants. These recombinants produced plaques that were significantly smaller than those produced by parental FPV or by FPV recombinants containing the gene at other non-essential sites. Insertion of foreign DNA into the I site disrupts a previously unidentified open reading frame (ORF) which potentially encodes a 74K polypeptide. The predicted amino acid sequence of this FPV ORF has 24% identity with the F12L ORF of vaccinia virus, the function of which is not currently known. Production of intracellular FPV was similar in cells infected with recombinant or parental viruses, but the number of infectious extracellular virions released into the medium by the recombinant was about 20% of that released by the parental virus. Likewise, the release of FPV particles, which were labelled with [H]thymidine, was significantly lower in recombinant FPV-infected cells. These results suggest that the FPV homologue of the vaccinia virus F12L ORF is involved in the envelopment or release of infectious extracellular virions.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-1-55
1993-01-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/1/JV0740010055.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-1-55&mimeType=html&fmt=ahah

References

  1. Arhelger RB, Randall CC. 1964; Electron microscopic observations on the development of fowlpox virus in chorioallantoic membrane. Virology 22:59–66
    [Google Scholar]
  2. Bayliss CD, Peters RW, Cook JKA, Reece RL, Howes K, Binns MM, Boursnell MEG. 1991; A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Archives of Virology 120:193–205
    [Google Scholar]
  3. Beard CW, Schnitzlein WM, Tripathy DN. 1991; Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Diseases 35:356–359
    [Google Scholar]
  4. Blasco R, Moss B. 1991; Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope protein. Journal of Virology 65:5910–5920
    [Google Scholar]
  5. Blasco R, Moss B. 1992; Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. Journal of Virology 66:4170–4179
    [Google Scholar]
  6. Bostock CJ. 1990; Viruses as vectors. Veterinary Microbiology 23:55–71
    [Google Scholar]
  7. Boulter EA, Appleyard G. 1973; Differences between extracellular and intracellular forms of poxvirus and their implications. Progress in Medical Virology 16:86–108
    [Google Scholar]
  8. Boursnell MEG, Green PF, Campbell GIA, Deuter A, Peters RW, Tomley FM, Samson ACR, Chambers P, Emmerson PT, Binns MM. 1990a; Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant. Journal of General Virology 71:621–628
    [Google Scholar]
  9. Boursnell MEG, Green PF, Samson ACR, Campbell JIA, Deuter A, Peters RW, Millar NS, Emmerson PT, Binns MM. 1990b; A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology 178:297–300
    [Google Scholar]
  10. Boyle DB, Coupar BEH. 1998; Construction of recombinant fowlpox viruses as vectors for poultry vaccines. Virus Research 10:343–356
    [Google Scholar]
  11. Calvert JG, Ogawa R, Yanagida N, Nazerian K. 1992; Identification and functional analysis of the fowlpox virus homolog of the vaccinia virus p37K major envelope antigen gene. Virology (in press)
    [Google Scholar]
  12. Coupar BEH, Teo T, Boyle DB. 1990; Restriction endonuclease mapping of the fowlpox virus genome. Virology 179:159–167
    [Google Scholar]
  13. Dallo S, Rodriguez F, Esteban M. 1987; A 14K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus. Virology 159:423–432
    [Google Scholar]
  14. Devereux J, Haeberli P, Smithies O. 1984; A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Research 12:387–395
    [Google Scholar]
  15. Dhawale S, Beisel CE, Nazerian K. 1990; Transient expression assay for qualitative assessment of gene expression by fowlpox virus. Virus Genes 3:213–220
    [Google Scholar]
  16. Duncan SA, Smith GL. 1992; Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. Journal of Virology 66:1610–1621
    [Google Scholar]
  17. Edbauer C, Weinberg R, Taylor J, Reysenelonge A, Bouquet JF, Desmettre P, Paoletti E. 1990; Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemagglutinin-neuraminidase gene. Virology 179:901–904
    [Google Scholar]
  18. Fernandes G, Sharma SN, Tanwani SK. 1981; Studies on tissue culture adapted fowl pox disease vaccine with particular reference to immunogenicity of intracellular and extracellular virus. Indian Veterinary Journal 58:599–604
    [Google Scholar]
  19. Goebel SJ, Johnson GP, Perkus ME, Davis SW, Winslow JP, Paoletti E. 1990; The complete DNA sequence of vaccinia virus. Virology 179:247–266
    [Google Scholar]
  20. Gonnet GH, Cohen MA, Benner SA. 1992; Exhaustive matching of the entire protein sequence database. Science 256:1443–1445
    [Google Scholar]
  21. Hiller G, Weber K. 1985; Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. Journal of Virology 55:651–659
    [Google Scholar]
  22. Hirt P, Hiller G, Witter R. 1986; Localization and fine structure of a vaccinia virus gene encoding an envelope antigen. Journal of Virology 58:757–764
    [Google Scholar]
  23. Hruby DE. 1990; Vaccinia virus vectors: new strategies for producing recombinant vaccines. Clinical Microbiology Reviews 3:153–170
    [Google Scholar]
  24. Kumar S, Boyle DB. 1990a; A poxvirus bidirectional promoter element with early/late and late functions. Virology 179:151–158
    [Google Scholar]
  25. Kumar S, Boyle DB. 1990b; Mapping of a major early/late gene of fowlpox virus. Virus Research 15:175–186
    [Google Scholar]
  26. Kumar S, Boyle DB. 1990c; Activity of a fowlpox virus late gene promoter in vaccinia and fowlpox virus recombinants. Archives of Virology 112:139–148
    [Google Scholar]
  27. Kyte J, Doolittle RF. 1982; A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology 157:105–132
    [Google Scholar]
  28. Letellier C, Burny A, Meulemans G. 1991; Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge. Archives of Virology 118:143–156
    [Google Scholar]
  29. Mahr A, Payne LG. 1992; Vaccinia recombinants as vaccine vectors. Immunobiology 184:126–146
    [Google Scholar]
  30. Maiti NK, Oberoi MS, Sharma SN. 1991; Comparative studies on the antigenicity of extracellular and intracellular viruses of fowl pox. Comparative Immunology, Microbiology, and Infectious Diseases 14:59–62
    [Google Scholar]
  31. Moss B. 1990a; Regulation of vaccinia virus transcription. Annual Review of Biochemistry 59:661–668
    [Google Scholar]
  32. Moss B. 1990b; Poxviridae and their replication. In Virology pp , 2nd edn.2079–2111Edited by Fields BN, Knipe DM. New York: Raven Press;
    [Google Scholar]
  33. Moss B. 1991; Vaccinia virus: a tool for research and vaccine development. Science 252:1662–1667
    [Google Scholar]
  34. Moss B, Ahn BY, Amegadzie B, Gershon PD, Keck JG. 1991; Cytoplasmic transcription system encoded by vaccinia virus. Journal of Biological Chemistry 266:1355–1358
    [Google Scholar]
  35. Nazerian K, Dhawale S, Payne WS. 1989; Cytoplasmic transcription system encoded by vaccinia virus. Structural proteins of two different plaque-size phenotypes of fowlpox virus 33:458–465
    [Google Scholar]
  36. Nazerian K, Lee LF, Yanagida N, Ogawa R. 1992; Protection against Marek’s disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek’s disease virus. Journal of Virology 66:1409–1413
    [Google Scholar]
  37. Ogawa R, Yanagida N, Saeki S, Saito S, Ohkawa S, Gotoh H, Kodama K, Kamogawa K, Sawaguchi K, Iritani Y. 1990; Recombinant fowlpox viruses inducing protective immunity against Newcastle disease and fowlpox viruses. Vaccine 8:486–490
    [Google Scholar]
  38. Payne LG. 1980; Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. Journal of General Virology 50:89–100
    [Google Scholar]
  39. Pincus S, Mason PW, Konishi E, Fonseca BA. L, Shope RE, Rice CM, Paoletti E. 1992; Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. Virology 187:290–297
    [Google Scholar]
  40. Prideaux CT, Kumar S, Boyle DB. 1990; Comparative analysis of vaccinia virus promoter activity in fowlpox and vaccinia virus recombinants. Virus Research 16:43–58
    [Google Scholar]
  41. Rodriguez JF, Smith GL. 1990; IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Research 18:5347–5351
    [Google Scholar]
  42. Sambrook J, Fritsch EF, Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  43. Schmutz C, Payne LG, Gubser J, Witter R. 1991; A mutation in the gene encoding the vaccinia virus 37,000 Mr protein confers resistance to an inhibitor of virus envelopment and release. Journal of Virology 65:3435–3442
    [Google Scholar]
  44. Schnitzlein W, Ghildyal N, Tripathy DN. 1988; Genomic and antigenic characterization of avipoxviruses. Virus Research 10:65–76
    [Google Scholar]
  45. Smith G, Moss B. 1983; Infectious poxvirus vectors have the capacity for at least 25,000 base pairs of foreign DNA. Gene 25:21–28
    [Google Scholar]
  46. Solomon JJ. 1975; Preparation of avian cell cultures. Tissue Culture Association 1:7–11
    [Google Scholar]
  47. Spehner D, Drillien R, Lecocq J-P. 1990; Construction of fowlpox virus vectors with intergenic insertions: expression of the fl-galactosidase gene and the measles virus fusion gene. Journal of Virology 64:527–533
    [Google Scholar]
  48. Spyropoulos DD, Stallard V, Roberts BE, Cohen LK. 1991; Utilization of DNA recombination for the two-step replacement of growth factor sequences in the vaccinia virus genome. Journal of Virology 65:4609–4618
    [Google Scholar]
  49. Takahashi-Nishimaki F, Funahashi SI, Miki K, Hashizume S, Sugimoto M. 1991; Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins. Virology 181:158–164
    [Google Scholar]
  50. Tartaglia J, Pincus S, Paoletti E. 1990; Poxvirus-based vectors as vaccine candidates. Critical Reviews in Immunology 10:13–30
    [Google Scholar]
  51. Taylor J, Paoletti E. 1988; Fowlpox virus as a vector in nonavian species. Vaccine 6:466–468
    [Google Scholar]
  52. Taylor J, Weinberg R, Kawaoka Y, Webster RG, Paoletti E. 1988; Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 6:504–508
    [Google Scholar]
  53. Taylor J, Edbauer C, Rey-Senelonge A, Bouquet JF, Norton E, Goebel SJ, Dbsmettre P, Paoletti E. 1990; Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. Journal of Virology 64:1441–1450
    [Google Scholar]
  54. Taylor J, Trimarchi C, Weinberg R, Languet B, Guillemin F, Desmettre P, Paoletti E. 1991; Efficacy studies on a canarypox-rabies recombinant virus. Vaccine190–193
    [Google Scholar]
  55. Taylor J, Weinberg R, Tartaglia J, Richardson C, Alkhatib G, Briedis D, Appel M, Norton E, Paoletti E. 1992; Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 187:321–328
    [Google Scholar]
  56. Tomley F, Binns M, Campbell J, Boursnell M. 1988; Sequence analysis of an 11-2 kilobase, near-terminal, BamHl fragment of fowlpox virus. Journal of General Virology 69:1025–1040
    [Google Scholar]
  57. Tripathy DN. 1991; Pox. In Diseases of Poultry, 9th edn. pp 583–596Edited by Calnek BW, Barnes HJ, Beard CW, Reid WM, Yoder Jr HW. Ames: Iowa State University Press;
    [Google Scholar]
  58. Venkatesan S, Baroudy BM, Moss B. 1981; Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene. Cell 25:805–813
    [Google Scholar]
  59. Wild F, Giraudon P, Spehner D, Drillien R, Lecocq JP. 1990; Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitis. Vaccine 8:441–142
    [Google Scholar]
  60. Yanagida N, Saeki S, Ogawa R, Saito S, Ohkawa S, Gotoh H, Kodama K, Kamogawa K, Sawaguchi K, Iritani Y. 1990; Protective immunity against Newcastle disease virus induced by fowl poxvirus recombinants. In Vaccines 90: Modern Approaches to New Vaccines Including Prevention of AIDS pp 85–89Edited by Brown F, Chanock RM, Ginsberg HS, Lerner RA. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  61. Yanagida N, Ogawa R, Li Y, Lee LF, Nazerian K. 1992; Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 gene of Marek’s disease virus. Journal of Virology 66:1402–1408
    [Google Scholar]
  62. Yuen L, Moss B. 1987; Oligonucleotide sequence signaling transcription termination of vaccinia virus early genes. Proceedings of the National Academy of Sciences, U.S.A. 84:6417–6421
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-1-55
Loading
/content/journal/jgv/10.1099/0022-1317-74-1-55
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error